Palantir's Week in Review: AI Disruption Fears, Insider Sales, and Sector Panic

Core Viewpoint - Palantir Technologies (PLTR) shares declined by 3.3% this week, reflecting concerns over valuation, ongoing insider selling, and the company's ability to secure new contracts despite strong revenue growth in Q4 [1] Group 1: Market Performance - Palantir's stock closed at $131.41, marking a year-to-date decline of 26%, while the S&P 500 fell only 1.3% during the same period [1] - The iShares Tech-Expanded Software ETF dropped over 3% on February 11, contributing to the selloff of Palantir shares [1] Group 2: Insider Selling - All insider transactions from November 15, 2025, to February 13, 2026, were sales, with no purchases recorded [1] - CEO Alex Karp sold shares between $147 and $151 on February 2, while COO Shyam Sankar liquidated 149,872 shares on November 20 [1] - Director Alexander Moore executed 16 transactions on January 2, selling shares at prices ranging from $167 to $181 [1] Group 3: Customer Contracts and Adoption - OneMedNet reported $2.79 million in bookings for 2025, a 4.1x increase year-over-year, attributed to Palantir-powered subscription offerings [1] - Innodata signed a deal for high-quality training data and multimodal AI engineering with Palantir [1] - FTAI Aviation partnered with Palantir for a multi-year AI operations platform [1] Group 4: Valuation and Market Sentiment - Morningstar raised its fair value estimate for Palantir to $150 per share, citing strong U.S. commercial adoption and the company's unique ontological framework [1] - Despite strong customer adoption and contract growth, Palantir's stock trades 26% below year-end levels, closer to its 52-week low of $66 than its high of $207 [1] - The company's 205x P/E ratio indicates a valuation standoff amid sector-wide selling pressure and relentless insider selling [1]